BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22013)

  • 1. Mineralocorticoid radioreceptor assay: application to adrenal-regeneration hypertension.
    Gomez-Sanchez C; Holland OB; Murry BA
    Life Sci; 1977 Oct; 21(7):989-96. PubMed ID: 22013
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered secretion of corticosteroids and prolactin in adrenal regeneration hypertensive rats.
    Mimou N; Takeda R
    Endocrinol Jpn; 1992 Apr; 39(2):185-96. PubMed ID: 1396350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoids and mineralocorticoid receptors in mononuclear leukocytes in patients with pregnancy-induced hypertension.
    Wacker J; E-Mistry N; Bauer H; Vecsei P; Stolz W; Bastert G
    J Clin Endocrinol Metab; 1992 Apr; 74(4):910-3. PubMed ID: 1312541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
    Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
    Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoids, salt and high blood pressure.
    Gómez-Sánchez EP; Zhou M; Gomez-Sanchez CE
    Steroids; 1996 Apr; 61(4):184-8. PubMed ID: 8732997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of 16beta-hydroxydehydroepiandrosterone with renal mineralocorticoid receptors.
    Higgins JR; Wambach G; Kem DC; Gomez-Sanchez C; Holland OB; Kaplan NM
    J Lab Clin Med; 1977 Feb; 89(2):250-6. PubMed ID: 137938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
    Yamakawa M; Ezumi K; Shiro M; Nakai H; Kamata S; Matsui T; Haga N
    Mol Pharmacol; 1986 Dec; 30(6):585-9. PubMed ID: 3023811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for agonistic and antagonistic mineralocorticoids.
    Genard P; Palem-Vliers P
    J Steroid Biochem; 1980 Nov; 13(11):1299-305. PubMed ID: 6256585
    [No Abstract]   [Full Text] [Related]  

  • 9. Mineralocorticoid receptor-like aldosterone-binding protein in cell culture.
    Lan NC; Matulich DT; Morris JA; Baxter JD
    Endocrinology; 1981 Dec; 109(6):1963-70. PubMed ID: 6273124
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoid and mineralocorticoid receptors for aldosterone.
    Rousseau G; Baxter JD; Funder JW; Edelman IS; Tomkins GM
    J Steroid Biochem; 1972 Feb; 3(2):219-27. PubMed ID: 4346760
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the role of the central nervous system in mineralocorticoid hypertension?
    Gómez Sánchez EP
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):374-81. PubMed ID: 1647798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of mineralocorticoid-induced hypertension: evidence for the presence of an in-situ mechanism in the arterial wall for a direct action of mineralocorticoids.
    Kornel L
    Clin Biochem; 1981 Oct; 14(5):282-93. PubMed ID: 7037229
    [No Abstract]   [Full Text] [Related]  

  • 13. Paradoxical nature of mineralocorticoid receptor antagonism by progestins.
    Agarwal MK; Paillard J
    Biochem Biophys Res Commun; 1979 Jul; 89(1):77-84. PubMed ID: 573122
    [No Abstract]   [Full Text] [Related]  

  • 14. Mineralocorticoid receptors in the rat lung.
    Krozowski Z; Funder JW
    Endocrinology; 1981 Dec; 109(6):1811-3. PubMed ID: 6273117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mineralocorticoid agonist and antagonist specific receptors from rat kidney.
    Agarwal MK; Kalimi M
    Biochem Biophys Res Commun; 1987 Feb; 143(1):398-402. PubMed ID: 3030321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid hormones.
    Stockigt JR
    Adv Steroid Biochem Pharmacol; 1976; 5():161-238, 334-5. PubMed ID: 180781
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension and low plasma renin activity: presumptive evidence for mineralocorticoid excess.
    Spark RF; Melby JC
    Ann Intern Med; 1971 Dec; 75(6):831-6. PubMed ID: 5134893
    [No Abstract]   [Full Text] [Related]  

  • 18. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of adrenal mineralocorticoids in hypertension.
    Tuck M
    Geriatrics; 1978 Jan; 33(1):77-83. PubMed ID: 620928
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
    Lan NC; Matulich DT; Stockigt JR; Biglieri EG; New MI; Winter JS; McKenzie JK; Baxter JD
    Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.